These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 25434634)

  • 101. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for First Relapse of Ovarian Cancer.
    Classe JM; Glehen O; Decullier E; Bereder JM; Msika S; Lorimier G; Abboud K; Meeus P; Ferron G; Quenet F; Marchal F; Gouy S; Pomel C; Pocard M; Guyon F; Bakrin N;
    Anticancer Res; 2015 Sep; 35(9):4997-5005. PubMed ID: 26254399
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Progress in the management of primary and recurrent ovarian carcinomatosis with peritonectomy procedure and HIPEC in a high volume centre.
    Arjona-Sanchez A; Rufián-Peña S
    Int J Hyperthermia; 2017 Aug; 33(5):554-561. PubMed ID: 28540830
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Cost-effectiveness of hyperthermic intraperitoneal chemotherapy (HIPEC) at interval debulking of epithelial ovarian cancer following neoadjuvant chemotherapy.
    Lim SL; Havrilesky LJ; Habib AS; Secord AA
    Gynecol Oncol; 2019 May; 153(2):376-380. PubMed ID: 30718126
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Treatment of ovarian metastases of colorectal and appendiceal carcinoma in the era of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Kuijpers AM; Mehta AM; Aalbers AG; van Driel WJ; Boot H; Verwaal VJ
    Eur J Surg Oncol; 2014 Aug; 40(8):937-42. PubMed ID: 24630923
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in pediatric ovarian tumors: a novel treatment approach.
    Hayes-Jordan A; Lopez C; Green HL; Xiao LC; Huh W; Herzog CE
    Pediatr Surg Int; 2016 Jan; 32(1):71-3. PubMed ID: 26500075
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Role of surgery and hyperthermic intraperitoneal chemotherapy in ovarian cancer.
    Kim SI; Kim JW
    ESMO Open; 2021 Jun; 6(3):100149. PubMed ID: 33984680
    [TBL] [Abstract][Full Text] [Related]  

  • 107. A comparison of primary intraperitoneal chemotherapy to consolidation intraperitoneal chemotherapy in optimally resected advanced ovarian cancer.
    Suidan RS; St Clair CM; Lee SJ; Barlin JN; Long Roche KC; Tanner EJ; Sonoda Y; Barakat RR; Zivanovic O; Chi DS
    Gynecol Oncol; 2014 Sep; 134(3):468-72. PubMed ID: 25042672
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Hyperthermic intraperitoneal chemotherapy (HIPEC) for gynecological cancer.
    Tsuyoshi H; Inoue D; Kurokawa T; Yoshida Y
    J Obstet Gynaecol Res; 2020 Sep; 46(9):1661-1671. PubMed ID: 32715605
    [TBL] [Abstract][Full Text] [Related]  

  • 109. [Intraperitoneal chemotherapy in the treatment of advanced ovarian cancer].
    Classe JM; Muller M; Frenel JS; Berton Rigaud D; Ferron G; Jaffré I; Gladieff L
    J Gynecol Obstet Biol Reprod (Paris); 2010 May; 39(3):183-90. PubMed ID: 20116179
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Establishing evidence for change in ovarian cancer surgery--proposing clinical trials of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer peritoneal carcinomatosis.
    Chua TC; Liauw W; Robertson G; Morris DL
    Gynecol Oncol; 2009 Oct; 115(1):166-168. PubMed ID: 19604568
    [No Abstract]   [Full Text] [Related]  

  • 111. Hyperthermic intraperitoneal chemotherapy for treating ovarian cancer.
    Gajarawala S; Pelkowski J; Dorian R; Stanton A; Dinh T
    JAAPA; 2021 Aug; 34(8):50-53. PubMed ID: 34320542
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Re: "cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: multi-institutional phase II trial." - Proposal of a clinical trial of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in advanced ovarian cancer, the CHORINE study.
    Ansaloni L; De Iaco P; Frigerio L
    Gynecol Oncol; 2012 Apr; 125(1):279-81. PubMed ID: 22233688
    [No Abstract]   [Full Text] [Related]  

  • 113. Hyperthermic intraperitoneal chemotherapy for ovarian cancer: The heat is on.
    Koole SN; van Driel WJ; Sonke GS
    Cancer; 2019 Dec; 125 Suppl 24():4587-4593. PubMed ID: 31967678
    [TBL] [Abstract][Full Text] [Related]  

  • 114. A retrospective study comparing the efficacy of dose-dense chemotherapy, intraperitoneal chemotherapy and dose-dense chemotherapy with hyperthermic intraperitoneal chemotherapy in the treatment of advanced stage ovarian carcinoma.
    Rettenmaier MA; Micha JP; Bohart R; Goldstein BH
    Eur J Obstet Gynecol Reprod Biol; 2020 Jan; 244():101-105. PubMed ID: 31778904
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Peritonectomy and hyperthermic intraperitoneal chemotherapy for advanced epithelial ovarian cancer: What gynaecological oncologists really think.
    Farrell R
    Aust N Z J Obstet Gynaecol; 2019 Jun; 59(3):457-462. PubMed ID: 30917208
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Hyperthermic intraperitoneal chemotherapy added to the treatment of ovarian cancer. A review of achieved results and complications.
    Dovern E; de Hingh IH; Verwaal VJ; van Driel WJ; Nienhuijs SW
    Eur J Gynaecol Oncol; 2010; 31(3):256-61. PubMed ID: 21077465
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Upfront HIPEC and bevacizumab-containing adjuvant chemotherapy in advanced epithelial ovarian cancer.
    Paris I; Cianci S; Vizzielli G; Fagotti A; Ferrandina G; Gueli Alletti S; Costantini B; Cosentino F; Capoluongo E; Pasqualoni M; Scambia G
    Int J Hyperthermia; 2018; 35(1):370-374. PubMed ID: 30300042
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Is peritonectomy and hyperthermic intraperitoneal chemotherapy a new standard of treatment for advanced epithelial ovarian cancer?
    Farrell R
    Aust N Z J Obstet Gynaecol; 2019 Jun; 59(3):335-340. PubMed ID: 30706448
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Intraperitoneal chemotherapy from Armstrong to HIPEC: challenges and promise.
    Eskander RN; Cripe J; Bristow RE
    Curr Treat Options Oncol; 2014 Mar; 15(1):27-40. PubMed ID: 24338278
    [TBL] [Abstract][Full Text] [Related]  

  • 120. It's time to warm up to hyperthermic intraperitoneal chemotherapy for patients with ovarian cancer.
    Zivanovic O; Chi DS; Filippova O; Randall LM; Bristow RE; O'Cearbhaill RE
    Gynecol Oncol; 2018 Dec; 151(3):555-561. PubMed ID: 30249527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.